FEATURED
Zhiyu Zhang, Xiaomeng You, Yingqi Hua, Xiaoyu Xu, Duoyi Zhao Frontiers Media SA
Science Pharmacology Pharmacology of Anti-Cancer Drugs
Keywords: chemotherapy,Immunotherapy,nanomaterials,translational medicine,clinical research
Hongwei Yao, Wen G. Jiang, Zhi-Chun Gu, Lin Zhao, Zhengyang Yang
Frontiers Media SA
Recently, immune checkpoint inhibitors (ICIs) have received a lot of attention to treat...
Keywords: immune checkpoint inhibitors,Gastrointestinal cancers,Immune-related adverse events
Syed Mahmood, Nur Akmarina Mohd Said, Kenneth K. W. To
The implication of tumour microenvironment (TME) on cancer progression and therapeutic response has...
Keywords: tumour microenvironment,Cancer,cancer-associated fibroblasts,Nanotherapeutics,Drug Discovery,drug repurposing
Yue Du, Shengxi Chen, Xiujun Liu, Lulu Wang
Amazing anticancer therapy advancements have been made in the last decade due to tremendous...
Keywords: Drug Resistance,cancer therapy,Mechanism,Reverse strategy,Novel drug
Ayaz Shahid, Pranav Kumar Prabhakar, Ajit Prakash, Saad Mustafa
Cancer is the second leading cause of death. Every year, many anticancer drug candidates are...
Keywords: anti-cancer,biomarkers,Drug Discovery,Immunotherapy,Gene Therapy,Phytomedicine,Cell signaling,Cell Cycle,Oncogenes,Protooncogenes,Cyclins,Cyclin dependent kinases
Luana Mota Ferreira, Marcel Henrique Marcondes Sari, Juliana Hofstatter Azambuja
Malignant melanoma is the most aggressive type of skin cancer with invasive growth patterns. Recent...
Health Oncology Pharmacology of Anti-Cancer Drugs
Keywords: Skin Cancer,Melanoma,immunology,Nanotechnology,Cancer biomarkers,Drug repositining,Immunotherapy
Rozangela Curi Pedrosa, Karina Felipe, Danilo Wilhelm Filho
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin...
Keywords: PI3KT/Akt/mTOR Pathway,Metabolism,Reactive Oxygen Species
Lin Qi, Ouyang Chen, Zhigang Liu, Hongzhou Cai
The adaptive immune resistance (AIR) mechanism refers to the various strategies employed by tumours...
Keywords: adaptive immune resistance,Immune Evasion,Immunotherapy,cancer therapy
Qun Xue, Jie Mei, Zichao Luo, Wenjun Mao, Yuan Wan, Yifei Liu
Health Medicine
Qin Wang, Lili Feng, Arif Gulzar, Chen Wang, Yang-Bao Miao
Hematologic malignancies (HMs) represent a group of hematologic cancers originating from bone...
Keywords: Hematologic malignancy,physiologic barrier,Anti-tumor therapy,Tumor Microenvironment
This action requires you to be registered with Frontiers and logged in. To register or login click here.
You are in
Pharmacology of Anti-Cancer Drugs
Frontiers Books is a bookstore-like platform that under a unique environment gathers all library services available at Frontiers. You may browse through the pages of Frontiers e-books and Abstract books, past hardcopy issues as well as other academic literature and download them for free in PDF and EPUB format.
Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.